Reducing Childbirth Related Fear And Preference For Caesarean Section: A RCT Of A Midwife-led Psycho-education Intervention (APRIME)
Funder
National Health and Medical Research Council
Funding Amount
$487,116.00
Summary
In 2008 34% of mothers had a caesarean section in Queensland. Women who are fearful are more likely to want and have a surgical delivery. We will recruit and train midwives to provide counselling and education about birth choices to fearful women during pregnancy. Our program (APRIME) enables women to work through fearful elements of childbirth, review their expectations/ experiences and develop a realistic plan. We predict that women receiving APRIME will report less fear and prefer a normal bi ....In 2008 34% of mothers had a caesarean section in Queensland. Women who are fearful are more likely to want and have a surgical delivery. We will recruit and train midwives to provide counselling and education about birth choices to fearful women during pregnancy. Our program (APRIME) enables women to work through fearful elements of childbirth, review their expectations/ experiences and develop a realistic plan. We predict that women receiving APRIME will report less fear and prefer a normal birth.Read moreRead less
Can Esomeprazole Improve Outcomes In Women At High Risk Of Pre-eclampsia? A Phase II Placebo-controlled Randomised, Multi-centre Clinical Trial.
Funder
National Health and Medical Research Council
Funding Amount
$1,597,125.00
Summary
Pre-eclampsia, recognised through the development of high blood pressure in pregnancy, causes death and/or injury to mothers and babies. An improved understanding of the development of pre-eclampsia has provided opportunities for early prediction and prevention of disease. We will use a powerful predictive model to identify pregnancies at high risk of pre-eclampsia then observe the effect of a novel treatment (esomeprazole) on maternal blood pressure and the development of this disease.
School-Age Outcomes Of Very Preterm Infants And Antenatal Magnesium Sulphate Therapy - A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$675,050.00
Summary
Despite recent major advances in care around the time of birth that have led to large increases in the survival rates for very preterm babies, the rate of adverse long-term health problems has not diminished in survivors, and remains too high compared with children not born very preterm. In particular they have higher rates of substantial problems with the way their brain works, particularly affecting their movement, vision, hearing, thinking and talking. We have just concluded a large clinical ....Despite recent major advances in care around the time of birth that have led to large increases in the survival rates for very preterm babies, the rate of adverse long-term health problems has not diminished in survivors, and remains too high compared with children not born very preterm. In particular they have higher rates of substantial problems with the way their brain works, particularly affecting their movement, vision, hearing, thinking and talking. We have just concluded a large clinical trial in Australia and New Zealand of magnesium sulphate which was given to mothers who were likely to deliver their baby too early (before 30 weeks of pregnancy). We have been able to show, for the first time, that magnesium sulphate was able to halve the rate of substantial problems with movement in 2 year old survivors, from 6% to 3%. However, we are not sure if this potentially important improvement will translate into better outcomes for the children as they grow older and reach school-age. As there are many examples of treatments given around the time of birth that have been shown to have some short-term benefits, but substantial long-term harms, we must be as certain as we can be that any advance in one small area of health is not counterbalanced by disadvantages in other health areas. We plan to assess the 1061 survivors from our earlier clinical trial of magnesium sulphate therapy at ages from 7-8 years, when they are at school. We will assess their movement and other important areas of their brain function, as well as their school progress and general health and growth. If we find important improvements in health at school-age of these children caused by magnesium sulphate therapy, without any substantial counterbalancing side-effects, magnesium sulphate will probably become standard therapy in mothers who are likely to deliver their baby very early. This will lead to a reduction in the burden of illness in the community caused by being born too early.Read moreRead less
Investigating The Relationship Between Depression, Anxiety And Nausea And Vomiting During Pregnancy: Causation Or Shared Liability?
Funder
National Health and Medical Research Council
Funding Amount
$600,874.00
Summary
Recent studies showing women who experience severe Nausea and vomiting during pregnancy (NVP) have higher rates of Anxiety and Depression prior to pregnancy have revived earlier hypotheses that NVP may have a psychogenic component. We hypothesize that Anxiety and Depression do not play a causal role in NVP but rather, the relationship is due to shared risk from genetic effects that influence both traits. We will test this hypothesis using genetic and epidemiological approaches.
Improving Primary Care For Aboriginal Mothers And Babies In The Kimberley Region Of Western Australia: A Population And Region Based Cluster Randomised Trial Driven By Local Health Service Providers
Funder
National Health and Medical Research Council
Funding Amount
$2,043,581.00
Summary
Over 50% of remote area Aboriginal mothers and 60% of breastfed infants have micronutrient malnutrition and other severe morbidities. A population based trial of a new locally driven model to improve the quality of maternal primary care will be undertaken. The primary outcome measure is improved iron deficiency anaemia in infants aged 6 months. The results will be used to develop improved primary care models and to improve health outcomes for all Aboriginal mothers and infants.
Midwives And Obstetricians Helping Mothers To Quit - The MOHMQuit Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,035,071.00
Summary
Smoking is the most important preventable cause of negative pregnancy outcomes. These outcomes are reduced if pregnant women stop smoking. Unfortunately, delivery of quitting support by health care professionals is currently poor. In this project we will trial an innovative program, MOHMQuit, which uses a whole-of-system approach to improve support provided to pregnant smokers and thus increase quitting among this critical group.
Vaginal Microbial Biomarkers For The Prevention Of Preterm Birth
Funder
National Health and Medical Research Council
Funding Amount
$579,763.00
Summary
Preterm birth is the leading cause of death and disability in children under 5 years of age. Bacterial infection triggers most preterm births but conventional antibiotic therapies are unsuccessful as a preventative treatment. We have a powerful new treatment, solithromycin, that should eradicate these infections, but to date, we are unable to identify women who would qualify for treatment. This study aims to use vaginal microbiological characteristics to identify early in pregnancy those women